According to a study to be presented at Digestive Disease Week (DDW) 2023, just 4% of patients with obesity who underwent bariatric surgery developed obesity-associated cancer in a 10-year follow-up, compared to 8.9% of those who did not have a weight-loss treatment.
A novel cell signalling route was discovered by researchers at the Johns Hopkins Kimmel Cancer Centre that may one day be used as a therapeutic target for people with aggressive pancreatic cancer.
Researchers have discovered how specific proteins within roundworm chromosomes enable their offspring to produce specialised cells generations later, a startling discovery that challenges the conventional wisdom that hereditary information for cell differentiation is primarily ingrained with
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
Mumbai (Maharashtra) [India], April 5 (ANI/NewsVoir): Cervical Cancer is India's second most common cancer, affecting more than 1.23 lakh women each year. Around 77,000 Indian women die of the disease. Despite being the only preventable cancers, awareness about effective and reliable screeni
This test is very useful for the diagnosis of many respiratory conditions like cancers, tuberculosis, hemoptysis etc; apart from having therapeutic indications.
New Delhi [India], March 24 (ANI/SRV): The term "cancer," a malignant illness viewed with panic, and anxiety, might make you feel shivery. The cancer diagnosis and treatment facilities, which are steadily experiencing a sea of changes, are rising along with the number of persons affected by
CAR T-cell treatments, which are specifically designed to target cancer cells, has heralded a new era in the treatment of human cancers, particularly hematologic malignancies. But all too frequently, they exhibit a disconcerting characteristic derived from the immune system's own cells: a sh
Personalization of cancer treatments has long been a goal--finding the right drugs that work for a patient's specific tumour based on specific genetic and molecular patterns. Many of these targeted therapies are highly effective, but they are not available for all cancers, including NSCLCs w
Human papillomavirus (HPV) has been linked to a rising number of head and neck cancers over the past ten years. For instance, research indicates that HPV is responsible for 70 per cent of oropharyngeal cancer cases in the US.